On February 27, several NHGRI researchers - Anastasia L. Wise, Ph.D., Shawn Burgess, Ph.D., and Brian P. Brooks, M.D., Ph.D.- will highlight the rare disease research that could benefit affected patients and also provide insight into more common disorders. They will underline this important relationship in advance of Rare Disease Day at NIH, a day-long symposium that is part of a global effort to raise awareness of rare diseases. The National Center for Advancing Translational Sciences and the NIH Clinical Center sponsor Rare Disease Day at NIH.
NHGRI believes that broadly sharing research data will result in maximum public benefit, and we're committed to providing researchers with access to genomic data. The National Institutes of Health (NIH) Genomic Data Sharing Policy establishes a system to promote data sharing, while also protecting research participants involved in genomics studies. We need your help to improve one of NIH's central data sharing tools for human genomic data: the database of Genotypes and Phenotypes, or dbGaP.
NHGRI's ENCODE Project has spent 13 years building a catalog of all the functional elements in the human genome sequence, and making it available to scientists worldwide for the study of human health and disease. On February 9, 2017, ENCODE program directors in the Division of Genome Sciences at NHGRI, and ENCODE researchers from the University of California, San Francisco, turned to Reddit - a social news website and discussion forum - to answer questions from the Reddit community. Here's an event recap.
The National Institutes of Health (NIH), in partnership with the American College of Medical Genetics and Genomics (ACMG), is seeking qualified physicians interested in acquiring credentials and experience to lead genomic medicine research and implementation programs at the NIH, major medical centers and other organizations. The goal of this fellowship is to increase the pool of physicians trained in managing research and implementation programs in genomic medicine.
Newly identified genes and genetic pathways in primary melanoma - the most serious form of skin cancer - could give researchers additional targets for developing new, personalized treatments for melanoma and, potentially, other cancers. Learning how these genes are expressed - turned on or off - could be used in the future to predict how and when the cancer cells will spread to other parts of the body and how fast they will grow. Read the study in the February 6, 2017, online issue of Pigment Cell and Melanoma Research.